Update on Medical Management of Benign Prostatic Hyperplasia
September 2008
in “
UK vet. Companion animal
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide → 
Studysummary This article updates on the medical management of benign prostatic hyperplasia in companion animals and reports no new clinical findings; the authors discuss existing treatments.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document reviewed the medical management of benign prostatic hyperplasia (BPH) in dogs, noting that castration was preferred for non-breeding males. For those unsuitable for surgery, treatments included delmadinone acetate, osaterone, and finasteride, each with specific benefits and side effects. Delmadinone could cause polyuria and polydipsia, osaterone was effective but might cause polyphagia and vomiting, and finasteride reduced prostate size without affecting semen quality but was contraindicated in breeding animals. Other treatments like GnRH agonists and flutamide were less commonly used. The document concluded that while various medical treatments were available, each had specific advantages and potential side effects.
